CEACAM5 and gastric cancer: The conventional serum-based biomarkers for GC, such as carcino-embryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9) and CA72-4, did not have favorable specificity and sensitivity, which always resulted in delayed diagnosis [7, 8].